跳至主要内容
临床试验/TCTR20221216001
TCTR20221216001招募中不适用

Metabolomics and transcriptomics study in coronary artery bypass graft

Faculty of medicine0 个研究点目标入组 80 人开始时间: 2022年12月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Coronary artery disease patients that indicated for CABG surgery
  • 2. Can perform informed consent patient
  • 3. Age more than 18 years

排除标准

  • 1. Requiring concomitant procedure
  • 2. Emergency surgery
  • 3. all types of atrial fibrillation
  • 4. Recent myocardial infarction not more than 2 weeks
  • 5. Other underlying diseases including neurologic disorders, chronic renal failure requiring dialysis, liver disease, active cancer, or any other serious medical condition.
  • 6. Absence of written informed consent
  • 7. Recent infection (fever 38.0 C, c-reactive protein (CRP) more than 20 mg/L,)
  • 8. Immune compromise including Anti-HIV, Hepatitis B or Hepatitis C infection, Treponema pallidum
  • 9. Pregnant or breastfeeding

研究者

发起方
Faculty of medicine

相似试验